Amylyx Pharmaceuticals (AMLX) News Today $4.28 +0.10 (+2.39%) (As of 12/17/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Fmr LLC Increases Holdings in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX)Fmr LLC grew its holdings in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Free Report) by 292.0% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 221,001 shares of the company's stock after acquiring an additional 164,622 shares during the quaDecember 18 at 3:11 AM | marketbeat.comCharles Schwab Investment Management Inc. Reduces Stake in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX)Charles Schwab Investment Management Inc. lessened its position in shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Free Report) by 42.1% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 302,270 shares of the company's stock after sDecember 18 at 3:11 AM | marketbeat.comAmylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Sees Significant Decrease in Short InterestAmylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Get Free Report) saw a significant drop in short interest in the month of November. As of November 30th, there was short interest totalling 1,450,000 shares, a drop of 5.2% from the November 15th total of 1,530,000 shares. Based on an average daily trading volume, of 1,440,000 shares, the days-to-cover ratio is presently 1.0 days. Approximately 3.4% of the company's shares are sold short.December 17 at 3:36 AM | marketbeat.comAmylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Shares Sold by Jacobs Levy Equity Management Inc.Jacobs Levy Equity Management Inc. trimmed its holdings in shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Free Report) by 18.8% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 478,440 shares of the company's stock afteDecember 9, 2024 | marketbeat.comAmylyx announces design of LUCIDITY clinical trialDecember 5, 2024 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: Keros Therapeutics (KROS), Century Therapeutics (IPSC)December 5, 2024 | markets.businessinsider.comWalleye Capital LLC Purchases 608,874 Shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX)Walleye Capital LLC grew its holdings in shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Free Report) by 986.5% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 670,594 shares of the comDecember 4, 2024 | marketbeat.comAlpha Wave Global LP Invests $2.17 Million in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX)Alpha Wave Global LP acquired a new stake in shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Free Report) during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 669,487 shares of the company's stock, valued at approxiNovember 27, 2024 | marketbeat.comAmylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Given Consensus Rating of "Moderate Buy" by BrokeragesAmylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Get Free Report) has received an average recommendation of "Moderate Buy" from the ten research firms that are presently covering the firm, MarketBeat.com reports. Five analysts have rated the stock with a hold recommendation, four have issued a buy recoNovember 26, 2024 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Raises Stake in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX)Connor Clark & Lunn Investment Management Ltd. increased its position in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Free Report) by 41.6% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor ownedNovember 25, 2024 | marketbeat.comAmylyx Pharmaceuticals (NASDAQ:AMLX) Stock Rating Upgraded by Baird R WBaird R W raised shares of Amylyx Pharmaceuticals from a "hold" rating to a "strong-buy" rating in a research note on Monday.November 19, 2024 | marketbeat.comBaird Upgrades Amylyx Pharmaceuticals (AMLX)November 19, 2024 | msn.comTwist Bioscience Posts Upbeat Results, Joins Tesla, Amylyx Pharmaceuticals, Regenxbio And Other Big Stocks Moving Higher On MondayNovember 18, 2024 | benzinga.comAmylyx upgraded to Outperform from Neutral at BairdNovember 18, 2024 | markets.businessinsider.comStrong Buy Rating for Amylyx Pharmaceuticals Inc. Driven by Promising Avexitide Prospects and Stable Financial StandingNovember 18, 2024 | markets.businessinsider.comAmylyx Pharmaceuticals upgraded to Outperform at Baird, shares riseNovember 18, 2024 | msn.comAmylyx Pharmaceuticals (NASDAQ:AMLX) Upgraded by Robert W. Baird to Outperform RatingRobert W. Baird upgraded shares of Amylyx Pharmaceuticals from a "neutral" rating to an "outperform" rating and upped their price target for the company from $3.00 to $11.00 in a research note on Monday.November 18, 2024 | marketbeat.comAmylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Short Interest UpdateAmylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Get Free Report) was the recipient of a significant growth in short interest in the month of October. As of October 31st, there was short interest totalling 1,290,000 shares, a growth of 27.7% from the October 15th total of 1,010,000 shares. Based on an average daily trading volume, of 1,340,000 shares, the short-interest ratio is currently 1.0 days. Approximately 3.1% of the shares of the company are sold short.November 15, 2024 | marketbeat.comCautious Hold on Amylyx Pharmaceuticals Amid Uncertainty in Pipeline ProgressNovember 11, 2024 | markets.businessinsider.comAmylyx Pharmaceuticals, Inc. (AMLX) Q3 2024 Earnings Call TranscriptNovember 9, 2024 | seekingalpha.comAmylyx Pharmaceuticals Q3 2024 Financial HighlightsNovember 9, 2024 | markets.businessinsider.comAmylyx Pharmaceuticals Inc (AMLX) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ...November 8, 2024 | finance.yahoo.comHC Wainwright Issues Positive Forecast for Amylyx Pharmaceuticals (NASDAQ:AMLX) Stock PriceHC Wainwright raised their price objective on Amylyx Pharmaceuticals from $8.00 to $12.00 and gave the company a "buy" rating in a research note on Friday.November 8, 2024 | marketbeat.comAmylyx Pharmaceuticals (AMLX) to Release Earnings on ThursdayAmylyx Pharmaceuticals (NASDAQ:AMLX) will be releasing earnings before the market opens on Thursday, November 7, Zacks reports.November 5, 2024 | marketbeat.comVentyx Biosciences: Ready To Escape "The Crash Cycle"November 5, 2024 | seekingalpha.comabrdn plc Has $6.39 Million Stake in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX)abrdn plc boosted its position in shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Free Report) by 1,567.9% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,972,242 shares of the company's stock aftNovember 3, 2024 | marketbeat.comBank of America Securities Reaffirms Their Buy Rating on Amylyx Pharmaceuticals Inc (AMLX)October 29, 2024 | markets.businessinsider.comPerceptive Advisors LLC's Strategic Acquisition in Amylyx Pharmaceuticals IncOctober 25, 2024 | finance.yahoo.comAmylyx Pharmaceuticals (NASDAQ:AMLX) Upgraded at Bank of AmericaBank of America upgraded shares of Amylyx Pharmaceuticals from a "neutral" rating to a "buy" rating and boosted their price objective for the stock from $4.20 to $10.00 in a research report on Wednesday.October 23, 2024 | marketbeat.comNeutral Stance on Amylyx Pharmaceuticals Amid Promising Data and UncertaintiesOctober 23, 2024 | markets.businessinsider.comAmylyx Pharmaceuticals (NASDAQ:AMLX) Receives "Buy" Rating from HC WainwrightHC Wainwright reissued a "buy" rating and set a $8.00 price objective on shares of Amylyx Pharmaceuticals in a research report on Friday.October 18, 2024 | marketbeat.comWhy Amylyx Pharmaceuticals Stock Was So Healthy This WeekOctober 18, 2024 | fool.comMillennium Management LLC Has $2.92 Million Stock Holdings in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX)Millennium Management LLC decreased its position in shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Free Report) by 38.9% during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,535,178 shares of the company's stock after seOctober 15, 2024 | marketbeat.comAmylyx Pharma (NASDAQ:AMLX) Stock, Short Interest ReportOctober 14, 2024 | benzinga.comAmylyx Pharmaceuticals Inc (AMLX) Q2 2024 Earnings Call Highlights: Strategic Pipeline ...October 9, 2024 | finance.yahoo.comAmerican Century Companies Inc. Reduces Stock Position in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX)American Century Companies Inc. cut its stake in shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Free Report) by 95.0% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 19,041 shares of the company's stock aftOctober 6, 2024 | marketbeat.comAmylyx Pharmaceuticals executive sells over $27k in company stockOctober 4, 2024 | investing.comAmylyx Pharmaceuticals executive sells over $36k in company stockOctober 4, 2024 | investing.comAmylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Shares Purchased by AQR Capital Management LLCAQR Capital Management LLC raised its stake in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Free Report) by 2,768.0% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,340,943 shares of the company's stock aftOctober 4, 2024 | marketbeat.comKuehn Law Encourages Investors of Amylyx Pharmaceuticals, Inc. to Contact Law FirmOctober 3, 2024 | prnewswire.comCamille L. Bedrosian Sells 11,442 Shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) StockOctober 3, 2024 | insidertrades.comInsider Selling: Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Insider Sells 11,442 Shares of StockAmylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Get Free Report) insider Camille L. Bedrosian sold 11,442 shares of the stock in a transaction on Monday, September 30th. The shares were sold at an average price of $3.20, for a total value of $36,614.40. Following the completion of the transaction, the insider now directly owns 143,801 shares in the company, valued at approximately $460,163.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.October 2, 2024 | marketbeat.comAlmitas Capital LLC Makes New Investment in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX)Almitas Capital LLC purchased a new position in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Free Report) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 1,903,851 shares of the company's stock, valued at approxiSeptember 29, 2024 | marketbeat.comXTX Topco Ltd Purchases New Holdings in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX)XTX Topco Ltd purchased a new stake in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 210,612 shares of the company's stock, valued at approSeptember 26, 2024 | marketbeat.comPharma Mar, S.A. (PMRA.F) Stock Price, News, Quote & History - Yahoo FinanceSeptember 23, 2024 | finance.yahoo.comReneo Pharmaceuticals And 2 Other Stocks Under $5 Executives Are BuyingSeptember 17, 2024 | benzinga.comAmylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) CFO Acquires $101,200.00 in StockSeptember 17, 2024 | insidertrades.comKuehn Law Encourages Investors of Amylyx Pharmaceuticals, Inc. to Contact Law FirmSeptember 16, 2024 | globenewswire.comShort Interest in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Declines By 24.4%Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Get Free Report) was the recipient of a large decline in short interest in August. As of August 31st, there was short interest totalling 1,490,000 shares, a decline of 24.4% from the August 15th total of 1,970,000 shares. Approximately 3.6% of the company's stock are short sold. Based on an average trading volume of 1,600,000 shares, the short-interest ratio is currently 0.9 days.September 15, 2024 | marketbeat.comAcadian Asset Management LLC Makes New Investment in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX)Acadian Asset Management LLC purchased a new position in shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 1,211,617 shares of the companSeptember 14, 2024 | marketbeat.com Get Amylyx Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AMLX and its competitors with MarketBeat's FREE daily newsletter. Email Address Vacuum up cash with these special trades? (Ad)Have you ever heard about a “volatility vacuum?” Most people haven’t. It all revolves around this formula right here. Now, the most important thing is that this equation — when applied to certain tickers at a certain time each month —- can trigger these “volatility vacuums.” And when that happens, anyone has the shot at sucking out payouts of $290, $350, even $1,350 in as little as 24 hours. (With just a $1k starting stake!) Granted, there were smaller wins and those that did not work out but best of all, we can know exactly when these opportunities will hit. I’ve used this info to create a Cash Calendar that lays out the precise dates of these payouts. And I’m sending it for FREE to anyone who joins me during my FREE training right here. AMLX Media Mentions By Week AMLX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AMLX News Sentiment▼0.950.71▲Average Medical News Sentiment AMLX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AMLX Articles This Week▼46▲AMLX Articles Average Week Get Amylyx Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AMLX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Rocket Pharmaceuticals News Today Bicycle Therapeutics News Today Avadel Pharmaceuticals News Today Septerna News Today Collegium Pharmaceutical News Today Zymeworks News Today Bicara Therapeutics News Today Gyre Therapeutics News Today Poseida Therapeutics News Today Cogent Biosciences News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AMLX) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersTrump’s Secret Manhattan ProjectOn January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...Banyan Hill Publishing | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | SponsoredWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | SponsoredMissed Nvidia? Buy Elon Musk’s “Silent Partner”In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my f...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amylyx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amylyx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AMLX Stock Alerts